4.82 USD
↘ 2.88 (37.40%)LIVE (AS OF 02:08 PM EDT)
Unicycive Therapeutics, Inc. Common Stock
UNCYNASDAQ • USD
Market: OPEN
UNCY is currently priced at $4.82. UNCY shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. UNCY is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 29, 2026.
Open?$4.00
High?$7.71
Low?$3.48
Prev. Close?$7.70
Volume?17.2M
Avg. Volume?1.3M
VWAP?$4.20
Rel. Volume?13.57x
Bid / Ask
Bid?$4.78 × 200
Ask?$4.79 × 100
Spread?$0.01
Midpoint?$4.79
Valuation & Ratios
Market Cap?210.9M
Shares Out?27.4M
Float?26.1M
Float %?97.8%
P/E Ratio?N/A
P/B Ratio?5.59
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Employees
22
Market Cap
195.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-13
Address
1975 W. EL CAMINO REAL, SUITE 204
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?9
Momentum?50
Short Sent.?35
Piotroski F-Score?0/9Weak
Altman Z-Score?0.84Distress
Confidence?52%Low
Short InterestHigh
Short % of Float?12.40%High
Short Interest?3.2M
Days to Cover?3.7
Free Float26.1M
Avg Daily Volume884.5K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.40Strong
Quick Ratio?2.40Strong
Cash Ratio?1.41Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.59FAIR▾
Peers100
S&P33
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-106.0%WEAK▾
S&P3
ROA?-62.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28671000
Enterprise Value?$173.6M
Fundamentals ratios updated end of day